Bhatnagar Anish Soleno Therapeutics Inc (SLNO) insider trading activity
Bhatnagar Anish is CHIEF EXECUTIVE OFFICER of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 719,553 shares of SLNO, which is worth approximately $32.1 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 21,633 shares (Common Stock) at a price of $49.8 per share, resulting in proceeds of $1,077,323. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
720K
2.92%
3M change
2861.49%
12M change
Total Value Held
$32.1 Million
Bhatnagar Anish Transaction History
BA
Bhatnagar Anish
CHIEF EXECUTIVE OFFICER
Redwood City, CA